patients are specifically excluded a two hour wait for all patients after each injection seems unnecessary.
Thus patient selection for immunotherapy is of the utmost importance. Injections should be given only where there is access to emergency drugs (especially adrenaline) and other resuscitative facilities. People giving the injections should be trained or be under the supervision of doctors trained in immunotherapy. Under these conditions any reactions would be self evident within a very short time after the injection if they were likely to be life threatening.
We conclude that injection immunotherapy with a biologically standardised extract in patients with severe pollen allergy should be considered in those who fail to respond adequately to conventional drug treatment. Patients should be carefully selected and the procedure carried out in a specialised centre.
We thank Allergologisk Laboratorium (ALK Denmark) for supplying Alutard SQ and placebo treatment packs, the Wellcome Foundation for supplying acrivastine 8 Main outcome measures and results-Blood samples were taken immediately before and after six months of oral contraceptive use and one, two, four, six, eight, and 12 weeks after the pill had been stopped. During the six months of oral contraceptive use the plasma concentration of factor X and fibrinogen increased and that of antithrombin III decreased. Between two and six weeks after stopping the pill a rebound phenomenon occurred with plasma concentrations of antithrombin III increasing (mean change from baseline at two weeks 0*06 IU/I and at six weeks 0-10 IU/l) and fibrinogen decreasing (0-26 g/l change at two weeks and 0*40 g/l at six weeks). Factor X concentrations fell gradually and the values at eight weeks were not significantly different from those found before the combined pill was started.
Conclusion-The combined pill should be stopped at least four weeks before major surgery, which carries the risk of postoperative thrombosis, to allow the potentially prothrombotic haemostatic changes that occur during its use to be coffected.
Introduction
The introduction and widespread use of the combined oral contraceptive has been associated with an increase in venous thromboembolism. assays. 6 Antithrombin III, plasminogen, a-2-antiplasmin, and protein C were determined by amidolytic microtitre assays. 17 Statistical analysis was performed by the repeated measures analysis of variance.'8 Duncan's multiple range test was used to control the overall level of significance for repeated testing. The mean of the changes from each woman's baseline value was used in the analysis as the main purpose of the study was to investiate the changes in the haemostatic variables once the combined pill was stopped.
The study was approved by the Middlesex Hospital ethics committee.
Results
Ofthe 24 women in the study, 13 took Marvelon and 11 took Femodene. Fourteen women completed the entire study, attending each visit; seven women missed one study visit, and three women missed two visits. Thus data for analysis was available from 24 women for the visit before the pill was started; 22 women for the visit after six months' use of the combined pill; and from 24, 23, 22, 24, 20, and 20 women for the visits one, two, four, six, eight, and 12 weeks, respectively, after the combined pill was stopped. The statistical analysis studied change within patients. At each time point the comparison relates those women who attended that study visit with their own baseline values. Although all the available data were analysed and presented to avoid bias by exclusion of dropouts, analysis restricted to the 14 women who attended each study visit showed the same trends as those presented here.
There was no significant difference between the two groups of women taking either of the combined oral contraceptive preparations in the changes seen in the haemostatic system when the combined pill was stopped. When the data from the two groups were combined, however, significant differences were found in the haemostatic variables measured both during and after oral contraceptive use as compared with baseline values.
The table shows mean baseline concentrations for each of the haemostatic variables measured, together with the mean change in concentration both during and for the 12 weeks after the combined pill was stopped. The more important changes are illustrated graphically in the figure.
Fibrinogen concentrations increased significantly in the six months of combined pill use but within one week of stopping the pill there was no difference from the baseline value. At two, six, and 12 weeks, however, concentrations were significantly below baseline, and fibrinogen antigen was closely correlated with clottable fibrinogen, indicating reduced synthesis.
Factor X concentrations increased significantly during pill use and gradually fell after the pill was stopped. At eight weeks there was no significant difference from baseline.
The plasma concentration of antithrombin III fell during oral contraceptive use but showed no significant difference from baseline within one week of stopping the pill. At four and six weeks the concentration was significantly higher than baseline.
Factor VII, protein C, and ax-2-antiplasmin did not show a significant change during the six months of pill use, but protein C and ca-2-antiplasmin showed significant but transient increases after the pill was stopped. The participants in this study were aged 35-45. The changes in the haemostatic system during oral contraceptive use are similar to those seen in younger women using the same preparations. It is thus unlikely that the changes found in the study group will differ greatly in younger women.
This study showed that changes in concentrations of coagulation factors occurring during use of the pill take several weeks to return to baseline values. Although the mean values for the coagulation factors were all within the normal range, the changes that occurred during oral contraceptive use-an increase in the coagulant factors fibrinogen and factor X, together with a reduction in antithrombin III not balanced by an increase in protein C or plasminogen levels-are potentially thrombogenic. We suggest that the changes shown in women using oral contraceptives add to the known thromboembolic risks of major surgery. This study implies that surgery is best performed after the combined pill has been stopped for at least four weeks. At this time fibrinogen concentration is low, antithrombin III concentration is high, and factor X concentration has nearly returned to control.
ONE HUNDRED YEARS AGO
A protest, influentially signed, is about to be addressed to the Home Secretary against the withdrawal of the muzzling regulations for the following reasons: -1. That until muzzling for twelve months be enforced simultaneously throughout Great Britain, followed by permanent quarantine, the extinction of rabies will be impossible, and that deaths from hydrophobia will by consequence inevitably recur in London. 2. That it has been abundantly proved by the experience of London alone, during the epidemics of 1885-86 and 1889-90, that deaths from hydrophobia cease after a period of muzzling, and that it is, therefore, painful to contemplate the risk of a recrudescence of the disease about to be incurred by the inhabitants of the metropolis, now that the muzzling regulation is replaced by a system which has utterly broken down in Vienna, Belgium, and Bradford. The memorialists also add that, after eighteen months' experience, many dog owners are now of opinion that muzzling in large cities is of inestimable benefit not only to mankind, who are thereby saved from the chance of contracting one of the most painful of diseases, but also to dogs, who are prevented by the muzzle from fighting with each other, from picking up garbage (by which they often suffer intensely), and from the risk of poisoning. As to the temporary good effects of the muzzling order while it lasted, Mr. Blanchard Wontner's statement before the magistrate at the Marylebone Police Court on the results attained in London during the year are very instructive. He said that in the year before the order was made there were 400 cases of rabies reported, mainly in London, and the number not reported would no doubt be large. During the three-quarters of the following year the number was reduced to 120, and in the four quarters of the year just closed the number of cases of rabies had been reduced to 15, 13, 8, and nil. (British MedicalJ3ournal 1891;i:82) BMJ VOLUME 302
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